Results of recombinant growth hormone treatment in children with end-stage renal disease on regular hemodialysis Full Text
Saudi Journal of Kidney Diseases and Transplantation, 07/11/2012
Clinical Article
Youssef DM – Recombinant human growth hormone (rhGH) therapy for patients with endstage renal disease on regular hemodialysis is helpful in height gain and catch–up growth even when given three–times per week instead of five– or six–times per week. The authors recommend giving rhGH therapy as a routine supplementation to pediatric patients before epiphyseal closure.



